These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


373 related items for PubMed ID: 32820208

  • 1. Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases.
    Ishiko S, Horinouchi T, Fujimaru R, Shima Y, Kaito H, Tanaka R, Ishimori S, Kondo A, Nagai S, Aoto Y, Sakakibara N, Nagano C, Yamamura T, Yoshimura M, Nakanishi K, Fujimura J, Kamiyoshi N, Nagase H, Yoshikawa N, Iijima K, Nozu K.
    Sci Rep; 2020 Aug 20; 10(1):14026. PubMed ID: 32820208
    [Abstract] [Full Text] [Related]

  • 2. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L, Peng L, Yang D, Chen S, Lan Z, Zhu X, Yuan S, Chen G, Liu Y, Liu H.
    Clin Immunol; 2020 Aug 20; 217():108483. PubMed ID: 32479989
    [Abstract] [Full Text] [Related]

  • 3. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y.
    Kidney Int; 2018 Mar 20; 93(3):700-705. PubMed ID: 29329643
    [Abstract] [Full Text] [Related]

  • 4. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
    Zhang K, Li Q, Zhang Y, Shang W, Wei L, Li H, Gao S, Yan T, Jia J, Liu Y, Lin S.
    Kidney Blood Press Res; 2019 Mar 20; 44(5):1196-1206. PubMed ID: 31574506
    [Abstract] [Full Text] [Related]

  • 5. Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients.
    Cheng W, Wang G, Guo W, Sun L, Xu X, Dong H, Ye S, Geng Y, Cheng H.
    Cells; 2022 Dec 28; 12(1):. PubMed ID: 36611910
    [Abstract] [Full Text] [Related]

  • 6. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
    Yasutake J, Suzuki Y, Suzuki H, Hiura N, Yanagawa H, Makita Y, Kaneko E, Tomino Y.
    Nephrol Dial Transplant; 2015 Aug 28; 30(8):1315-21. PubMed ID: 26109484
    [Abstract] [Full Text] [Related]

  • 7. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
    Sugiyama M, Wada Y, Kanazawa N, Tachibana S, Suzuki T, Matsumoto K, Iyoda M, Honda H, Shibata T.
    PLoS One; 2020 Aug 28; 15(4):e0232194. PubMed ID: 32324811
    [Abstract] [Full Text] [Related]

  • 8. Serum levels of galactose-deficient IgA1 in Chinese children with IgA nephropathy, IgA vasculitis with nephritis, and IgA vasculitis.
    Tang M, Zhang X, Li X, Lei L, Zhang H, Ling C, Ni J, Lv J, Liu X, Chen X.
    Clin Exp Nephrol; 2021 Jan 28; 25(1):37-43. PubMed ID: 32935202
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    Wada Y, Matsumoto K, Suzuki T, Saito T, Kanazawa N, Tachibana S, Iseri K, Sugiyama M, Iyoda M, Shibata T.
    PLoS One; 2018 Jan 28; 13(11):e0206865. PubMed ID: 30388165
    [Abstract] [Full Text] [Related]

  • 10. Utility of glomerular Gd-IgA1 staining for indistinguishable cases of IgA nephropathy or Alport syndrome.
    Ishiko S, Tanaka A, Takeda A, Hara M, Hamano N, Koizumi M, Ueno T, Hayashi H, Kondo A, Nagai S, Aoto Y, Sakakibara N, Nagano C, Horinouchi T, Yamamura T, Ninchoji T, Shima Y, Nakanishi K, Yoshikawa N, Iijima K, Nozu K.
    Clin Exp Nephrol; 2021 Jul 28; 25(7):779-787. PubMed ID: 33743099
    [Abstract] [Full Text] [Related]

  • 11. Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis.
    Zhang X, Xie X, Shi S, Liu L, Lv J, Zhang H.
    Nephrol Dial Transplant; 2020 Dec 04; 35(12):2117-2123. PubMed ID: 31377786
    [Abstract] [Full Text] [Related]

  • 12. cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy.
    Misaki T, Naka S, Suzuki H, Lee M, Aoki R, Nagasawa Y, Matsuoka D, Ito S, Nomura R, Matsumoto-Nakano M, Suzuki Y, Nakano K.
    PLoS One; 2023 Dec 04; 18(3):e0282367. PubMed ID: 36862654
    [Abstract] [Full Text] [Related]

  • 13. Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy.
    Irabu H, Shimizu M, Kaneko S, Inoue N, Mizuta M, Ohta K, Yachie A.
    J Immunol Res; 2020 Dec 04; 2020():4284379. PubMed ID: 32537466
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
    Rizk DV, Saha MK, Hall S, Novak L, Brown R, Huang ZQ, Fatima H, Julian BA, Novak J.
    J Am Soc Nephrol; 2019 Oct 04; 30(10):2017-2026. PubMed ID: 31444275
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy.
    Lee M, Suzuki H, Kato R, Fukao Y, Nakayama M, Kano T, Makita Y, Suzuki Y.
    CEN Case Rep; 2021 Feb 04; 10(1):17-22. PubMed ID: 32676896
    [Abstract] [Full Text] [Related]

  • 18. Associations of left renal vein entrapment with IgA nephropathy and Henoch-Schönlein purpura nephritis.
    Wang F, Zhu H, Bao S, Qi H, Xu L, Liu X, Zhai C, Yang X, Wang R.
    Ren Fail; 2022 Dec 04; 44(1):1519-1527. PubMed ID: 36069515
    [Abstract] [Full Text] [Related]

  • 19. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
    Martín-Penagos L, Fernández-Fresnedo G, Benito-Hernández A, Mazón J, de Cos M, Oviedo MV, San Segundo D, López-Hoyos M, Gómez-Román J, Ruiz JC, Rodrigo E.
    Nefrologia (Engl Ed); 2021 Dec 04; 41(3):311-320. PubMed ID: 36166247
    [Abstract] [Full Text] [Related]

  • 20. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
    Martín-Penagos L, Fernández-Fresnedo G, Benito-Hernández A, Mazón J, de Cos M, Oviedo MV, San Segundo D, López-Hoyos M, Gómez-Román J, Ruiz JC, Rodrigo E.
    Nefrologia (Engl Ed); 2021 Dec 04; 41(3):311-320. PubMed ID: 33741175
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.